1. 435 Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. (September 2015) Authors: Hodgson, D.R.; Dougherty, B.; Lai, Z.; Grinsted, L.; Spencer, S.; O'Connor, M.J.; Ho, T.W.; Robertson, J.D.; Lanchbury, J.; Timms, K.; Gutin, A.; Orr, M.; Jones, H.; Gilks, B.; Womack, C.; Sun, J.; Yelensky, R.; Gourley, C.; Ledermann, J.; Barrett, J.C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 458 DNA repair deficiencies in ovarian cancer: Genomic analysis of high grade serous ovarian tumors from the NOVA study. (September 2015) Authors: Timms, K.; Neff, C.; Abkevich, V.; Jones, J.T.; Kolquist, K.A.; Mirza, M.; Lanchbury, J.; Mikule, K.; Agarwal, S.; Hartman, A.R.; Gutin, A.; Wilcoxen, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 466 Next generation sequencing of BRCA1 and BRCA2 genes in ovarian tumors captures all germline mutations and expands the potential treatment group for the PARP inhibitor olaparib. (September 2015) Authors: Timms, K.; Neff, C.; Morris, B.; Hodgson, D.; Orr, M.; Zhongwu, L.; Fielding, A.; Dougherty, B.; Spencer, S.; Robertson, J.; Barrett, C.; Gutin, A.; Lanchbury, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗